Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Boobalan Pachaiyappan from Roth Capital issued a price target of $38.00 for CAPR on 2026-05-15 02:51:36.The adjusted price target was set to $38.00.At the time of the announcement,
May 15, 2026 CAPR -1.71%
from Craig-Hallum issued a price target of $7.00 for INVE on 2026-05-14 13:21:59.The adjusted price target was set to $7.00.At the time of the announcement, INVE was...
May 14, 2026 INVE -17.84%
from Roth Capital issued a price target of $7.00 for OVID on 2026-05-14 12:54:46.The adjusted price target was set to $7.00.At the time of the announcement, OVID...
May 14, 2026 OVID 0.00%
Boobalan Pachaiyappan from Roth Capital issued a price target of $19.00 for IMUX on 2026-05-14 12:51:02.The adjusted price target was set to $19.00.At the time of the announcement,
May 14, 2026 IMUX -2.28%
from Morgan Stanley issued a price target of $4.10 for ABSI on 2026-05-14 12:01:22.The adjusted price target was set to $4.10.At the time of the announcement, ABSI...
May 14, 2026 ABSI 4.53%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| IPHA Innate Pharma S.A. | 2.17
64.39% | ||||||||||||||||||
| IPWR Ideal Power Inc. | 7.38
37.17% | ||||||||||||||||||
| FENC Fennec Pharmaceuticals In | 9.24
36.48% | ||||||||||||||||||
| ONDS Ondas Holdings Inc. | 11.21
26.52% | ||||||||||||||||||
| JSPRW Jasper Therapeutics Inc | 0.01
25.47% | ||||||||||||||||||
| DERM Journey Medical Corporati | 6.35
22.35% | ||||||||||||||||||
| RDW Redwire Corporation | 13.99
22.08% | ||||||||||||||||||
| QSIAW Quantum-Si incorporated | 0.05
20.92% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.04%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -1.33%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.07%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.17%